Study Stopped
We were unable to continue field activities due to COVID-19
Linking Facility-based Mortality Audits With Community Engagement in Gilgit-Baltistan, Pakistan
A Pilot Study: Linking Facility-based Mortality Audits With Community Engagement to Improve Maternal and Newborn Outcomes in Gilgit-Baltistan, Pakistan
1 other identifier
interventional
1,871
1 country
1
Brief Summary
Pakistan is one of the countries in South Asia where neonatal mortality rates remain stagnant. Babies born in Pakistan encounter the highest risk of dying; of every 1,000 babies born, 46 die before the end of their first month (UNICEF, 2018). Some of the highest perinatal and neonatal mortality rates in Pakistan are found in districts of Pakistan's mountainous northern region (Bhutta ZA, 2013), where geography, climate and security risks make it challenging for women in remote communities to reach health services in a timely manner. According to 2013 PDHS, the neonatal and perinatal mortality rate in the northern area of Gilgit Baltistan was 39/1,000 and 37/1,000, respectively. In the rural area of Khyber Pakhtunkhwa, the neonatal and perinatal mortality rate was 42/1,000 and 63/1,000, respectively. Implementation of a health facility mortality audit cycle has proved successful in reducing perinatal mortality by upto 30% in other LMICs. Meanwhile evidence suggests that the most common factors contributing to high mortality rates are due to phase-one delays (delay in the decision to seek care). This study will attempt to operationalize linkages between the community and facility to not only improve facility-based quality of care, but to bring change in the community through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study will inform MoH policy decisions about standardized mortality audits with community feedback. Given the geographical location of Gilgit-Baltistan (GB) and accompanying constraints such as terrain and security, this study will attempt to operationalize linkages between the community and facility to not only improve facility-based quality of care, but to bring change in the community through community-feedback meetings to mitigate phase one and two delays and improve maternal, perinatal and neonatal outcomes. Data from this study will inform MoH policy decisions about standardized mortality audits with community feedback.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2019
CompletedFirst Posted
Study publicly available on registry
April 5, 2019
CompletedStudy Start
First participant enrolled
April 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2020
CompletedJuly 10, 2020
July 1, 2020
11 months
April 4, 2019
July 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in proportion of women who can correctly identify at least 3 danger signs at each stage across the continuum of care
Change in proportion of women who can correctly identify at least 3 danger signs at each stage across the continuum of care
12 months
Change in proportion of women for which at least 5 birthing plan actions were taken for the birth of the index child
Change in proportion of women for which at least 5 birthing plan actions were taken for the birth of the index child: Discussed place of delivery, Discussed who will perform delivery, Set aside funds for delivery, Set aside alternate funds for costs of skilled and emergency care, Made arrangements for transport, Identified a blood donor, Discussed accompaniment to planned delivery location.
12 months
Secondary Outcomes (6)
Change in number of facility deliveries
12 months
Change in severe maternal morbidity outcomes
12 months
Change in the quality of delivery services
12 months
Change in proportion of first, second and third delays
12 months
Perinatal mortality (fresh stillbirth or neonatal death in the first week of life)
12 months
- +1 more secondary outcomes
Study Arms (3)
Audits only
EXPERIMENTALFormalized audit teams with monthly meetings at each facility. Audit Intervention phases: 1. Identification of facility leadership (i.e physicians or leading health care providers) to be trained on best practices in obstetric and perinatal care in the implementation of the audits. 2. Training of identified audit leaders (main investigator is typically a physician) a. 5-day training workshop to include: i. Day 1: maternal death and near misses, perinatal, neonatal deaths and morbidity outcomes ii. Day 2: 'Three-delay' framework and identifying modifiable factors iii. Day 3: data collection and setting up the audit system iv. Days 4-5: mentoring on the identification of the audit teams and initiating audit implementation 3. Creating audit team (composed of at least two obstetricians, 2 pediatricians plus the main investigator) 4. Establishing and launching the audit cycle (monthly meetings) 5. Annual re-certification of audit leaders
Audits with community feedback
EXPERIMENTALThis intervention will implement the audits as described in arm 1; however, key community representatives (approximately 3-5 members) will be identified to attend monthly follow-up meetings with audit team leaders to discuss the community aspects (phase one and two-delays) that could have prevented the death, near miss or severe adverse outcome. Information regarding the cause(s) of death in the community will be collected by the LHW or CMW, who reports to the health facility on a monthly basis.
Control
NO INTERVENTIONMonthly outcome data will be collected from health facilities where no audits will be conducted. Data from this group will help evaluate the effectiveness of the intervention arms on perinatal and neonatal mortality.
Interventions
This intervention will implement the audits as described in arm 1; however, key community representatives (approximately 3-5 members) will be identified to attend monthly follow-up meetings with audit team leaders to discuss the community aspects (phase one and two-delays) that could have prevented the death, near miss or severe adverse outcome. Information regarding the cause(s) of death in the community will be collected by the LHW or CMW, who reports to the health facility on a monthly basis.
Eligibility Criteria
You may qualify if:
- Women aged 15-49 years who have had a pregnancy in the last 12 months who reside in the five targeted districts. Public and private health facilities in five districts in GB that offer obstetric and postnatal care, and respective catchment areas are supported by LHWs, Lady Health Volunteers (LHVs), CMWs, and CHWs will be included in the study. Data for all maternal 'near misses', perinatal and neonatal mortality and morbidity outcomes will be recorded for all women and newborns who deliver at home (through LHW, LHV, CMW monthly reports) and who contact the health facility within 42 days post-delivery, regardless of whether or not they delivered in the health facility.
You may not qualify if:
- Women aged 15-49 years who have not had a pregnancy in the last 12 months, who reside in the five targeted districts. Health facilities in five districts of GB that do not provide any obstetric and postnatal care and are not affiliated with any LHWs, or CMWs will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aga Khan Universitylead
- Aga Khan Foundation, Pakistancollaborator
- Aga Khan Health Servicescollaborator
- Centre for Global Child Health, SickKids Research Institute - Toronto, Canadacollaborator
- Aga Khan Development Network - Islamabad, Pakistancollaborator
- Department of Health Gilgit-Baltistan - Pakistancollaborator
- Aga Khan Foundation, Canadacollaborator
Study Sites (1)
Government and AKHSP Health Facilities in Gilgit-Baltistan
Gilgit, Astore, Ghizer, Hunza and Nagar, Gilgit-Baltistan, 74800, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sajid Soofi, FCPS, MBBS
Aga Khan University
- PRINCIPAL INVESTIGATOR
Diego Bassani, PhD
Centre for Global Child Health, SickKids Research Institute - Toronto, Canada
- PRINCIPAL INVESTIGATOR
Aminah Jahangir, MBBS, HPM
Aga Khan Foundation, Pakistan
- PRINCIPAL INVESTIGATOR
Zulfiqar A Bhutta, PhD
Centre for Global Child Health, SickKids Research Institute - Toronto, Canada
- PRINCIPAL INVESTIGATOR
Gul Nawaz Khan, MA, MPH
Aga Khan University
- PRINCIPAL INVESTIGATOR
Suzanne E Powell, MSc
Centre for Global Child Health, SickKids Research Institute - Toronto, Canada
- PRINCIPAL INVESTIGATOR
Miraj Uddin, MA
Aga Khan Health Services
- PRINCIPAL INVESTIGATOR
Saad Y Sulaimani, MSc
Aga Khan Foundation, Pakistan
- PRINCIPAL INVESTIGATOR
Asma Sittar, MSc
Aga Khan Development Network - Islamabad, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Health facilities (clusters) will be the units of randomization. Within each stratum, health facilities will be randomly allocated to one of the three arms. Arm 1: includes morbidity and mortality health facility audits-only; arm 2: includes morbidity and mortality health facility audits in addition to community-engagement; and arm 3: will serve as the control arm and collect outcome data only.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 4, 2019
First Posted
April 5, 2019
Study Start
April 16, 2019
Primary Completion
March 20, 2020
Study Completion
May 31, 2020
Last Updated
July 10, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share